Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: a pooled analysis | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: a pooled analysis

Asselah T, Reesink H, Gerstoft J, et al. Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: a pooled analysis. Liver Int. 2018;38(9):1583-1591.

Publication Type:

Journal Article

Authors:

Asselah, Tarik; Reesink, Hendrik; Gerstoft, Jan; et, al

Source:

Liver Int, Volume 38, Issue 9, p.1583-1591 (2018)

Keywords:

Elbasvir, Genotype 4, Grazoprevir, Hepatitis C, Ribavirin

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/29461687

Export Citation:

RIS Format

Top